The role of transforming growth factor-β in suppression of hepatic metastasis from colon cancer

Chandrakanth Are, Neka Simms, Ashwani Rajupt, Michael Brattain

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: The role of transforming growth factor-b (TGF-β) in the development of hepatic metastasis from colon cancer is not clearly elucidated. The aim of this study was to determine the role of TGF-β in the development of such metastasis. Methods: Two human colon cancer cell lines were utilized: FET-a cells (intact TGF-β inhibitory response), and CBS cells (defects in TGF-β inhibitory response caused by a deficiency in type II receptor activity). The ability of these cell lines to metastasize was analysed in an orthotopic colon cancer mouse model. Results: FET-a cells did not metastasize to the liver, but showed lung metastasis in 10% of the animals, whereas CBS cells gave rise to metastasis in 65%. Following the elimination of TGF-β activity by transfection and overexpression of dominant negative type II receptor, FET-a cells demonstrated liver and lung metastasis in 70% of the animals. Similarly, after the restoration of type II receptor activity by ectopic expression, CBS cells formed metastasis in fewer (10%) animals. Conclusions: The results of our study demonstrate for the first time that TGF-β displays selective metastasis suppressor activity. These abnormal pathways can serve as selective targets for future development of targeted therapies.

Original languageEnglish (US)
Pages (from-to)498-506
Number of pages9
JournalHPB
Volume12
Issue number7
DOIs
StatePublished - Sep 2010

Fingerprint

Transforming Growth Factors
Colonic Neoplasms
Neoplasm Metastasis
Liver
Cell Line
Lung
Transfection

Keywords

  • Basic science < liver
  • Colorectal metastases < liver

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

The role of transforming growth factor-β in suppression of hepatic metastasis from colon cancer. / Are, Chandrakanth; Simms, Neka; Rajupt, Ashwani; Brattain, Michael.

In: HPB, Vol. 12, No. 7, 09.2010, p. 498-506.

Research output: Contribution to journalArticle

Are, Chandrakanth ; Simms, Neka ; Rajupt, Ashwani ; Brattain, Michael. / The role of transforming growth factor-β in suppression of hepatic metastasis from colon cancer. In: HPB. 2010 ; Vol. 12, No. 7. pp. 498-506.
@article{f9e74b67046f40c79f8490ecfa5f517a,
title = "The role of transforming growth factor-β in suppression of hepatic metastasis from colon cancer",
abstract = "Background: The role of transforming growth factor-b (TGF-β) in the development of hepatic metastasis from colon cancer is not clearly elucidated. The aim of this study was to determine the role of TGF-β in the development of such metastasis. Methods: Two human colon cancer cell lines were utilized: FET-a cells (intact TGF-β inhibitory response), and CBS cells (defects in TGF-β inhibitory response caused by a deficiency in type II receptor activity). The ability of these cell lines to metastasize was analysed in an orthotopic colon cancer mouse model. Results: FET-a cells did not metastasize to the liver, but showed lung metastasis in 10{\%} of the animals, whereas CBS cells gave rise to metastasis in 65{\%}. Following the elimination of TGF-β activity by transfection and overexpression of dominant negative type II receptor, FET-a cells demonstrated liver and lung metastasis in 70{\%} of the animals. Similarly, after the restoration of type II receptor activity by ectopic expression, CBS cells formed metastasis in fewer (10{\%}) animals. Conclusions: The results of our study demonstrate for the first time that TGF-β displays selective metastasis suppressor activity. These abnormal pathways can serve as selective targets for future development of targeted therapies.",
keywords = "Basic science < liver, Colorectal metastases < liver",
author = "Chandrakanth Are and Neka Simms and Ashwani Rajupt and Michael Brattain",
year = "2010",
month = "9",
doi = "10.1111/j.1477-2574.2010.00219.x",
language = "English (US)",
volume = "12",
pages = "498--506",
journal = "HPB",
issn = "1365-182X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - The role of transforming growth factor-β in suppression of hepatic metastasis from colon cancer

AU - Are, Chandrakanth

AU - Simms, Neka

AU - Rajupt, Ashwani

AU - Brattain, Michael

PY - 2010/9

Y1 - 2010/9

N2 - Background: The role of transforming growth factor-b (TGF-β) in the development of hepatic metastasis from colon cancer is not clearly elucidated. The aim of this study was to determine the role of TGF-β in the development of such metastasis. Methods: Two human colon cancer cell lines were utilized: FET-a cells (intact TGF-β inhibitory response), and CBS cells (defects in TGF-β inhibitory response caused by a deficiency in type II receptor activity). The ability of these cell lines to metastasize was analysed in an orthotopic colon cancer mouse model. Results: FET-a cells did not metastasize to the liver, but showed lung metastasis in 10% of the animals, whereas CBS cells gave rise to metastasis in 65%. Following the elimination of TGF-β activity by transfection and overexpression of dominant negative type II receptor, FET-a cells demonstrated liver and lung metastasis in 70% of the animals. Similarly, after the restoration of type II receptor activity by ectopic expression, CBS cells formed metastasis in fewer (10%) animals. Conclusions: The results of our study demonstrate for the first time that TGF-β displays selective metastasis suppressor activity. These abnormal pathways can serve as selective targets for future development of targeted therapies.

AB - Background: The role of transforming growth factor-b (TGF-β) in the development of hepatic metastasis from colon cancer is not clearly elucidated. The aim of this study was to determine the role of TGF-β in the development of such metastasis. Methods: Two human colon cancer cell lines were utilized: FET-a cells (intact TGF-β inhibitory response), and CBS cells (defects in TGF-β inhibitory response caused by a deficiency in type II receptor activity). The ability of these cell lines to metastasize was analysed in an orthotopic colon cancer mouse model. Results: FET-a cells did not metastasize to the liver, but showed lung metastasis in 10% of the animals, whereas CBS cells gave rise to metastasis in 65%. Following the elimination of TGF-β activity by transfection and overexpression of dominant negative type II receptor, FET-a cells demonstrated liver and lung metastasis in 70% of the animals. Similarly, after the restoration of type II receptor activity by ectopic expression, CBS cells formed metastasis in fewer (10%) animals. Conclusions: The results of our study demonstrate for the first time that TGF-β displays selective metastasis suppressor activity. These abnormal pathways can serve as selective targets for future development of targeted therapies.

KW - Basic science < liver

KW - Colorectal metastases < liver

UR - http://www.scopus.com/inward/record.url?scp=77956893381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956893381&partnerID=8YFLogxK

U2 - 10.1111/j.1477-2574.2010.00219.x

DO - 10.1111/j.1477-2574.2010.00219.x

M3 - Article

C2 - 20815859

AN - SCOPUS:77956893381

VL - 12

SP - 498

EP - 506

JO - HPB

JF - HPB

SN - 1365-182X

IS - 7

ER -